{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T03:45:58Z","timestamp":1787802358265,"version":"build-2784847793"},"reference-count":26,"publisher":"Elsevier BV","issue":"24","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T00:00:00Z","timestamp":1650499200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.vaccine.2022.04.055","type":"journal-article","created":{"date-parts":[[2022,4,22]],"date-time":"2022-04-22T01:00:41Z","timestamp":1650589241000},"page":"3345-3355","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Predictors of hospitalisation and death due to SARS-CoV-2 infection in Finland: A population-based register study with implications to vaccinations"],"prefix":"10.1016","volume":"40","author":[{"given":"Heini","family":"Salo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2089-2299","authenticated-orcid":false,"given":"Toni","family":"Lehtonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kari","family":"Auranen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7456-8016","authenticated-orcid":false,"given":"Ulrike","family":"Baum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuija","family":"Leino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.vaccine.2022.04.055_b0005","doi-asserted-by":"crossref","first-page":"382","DOI":"10.15585\/mmwr.mm6913e2","article-title":"Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 \u2014 United States, February 12\u2013March 28, 2020","volume":"69","author":"Chow","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"12","key":"10.1016\/j.vaccine.2022.04.055_b0010","doi-asserted-by":"crossref","first-page":"343","DOI":"10.15585\/mmwr.mm6912e2","article-title":"Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) \u2014 United States, February 12\u2013March 16, 2020","volume":"69","author":"Bialek","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"18","key":"10.1016\/j.vaccine.2022.04.055_b0015","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical Characteristics of Coronavirus Disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2022.04.055_b0020","doi-asserted-by":"crossref","unstructured":"Guan WJ, Liang WH, Zhao Y, Liang HR, Chen ZS, Li YM et al. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. Eur Respir J 2020;55(5):10.1183\/13993003.00547,2020. Print 2020 May. https:\/\/doi.org\/10.1183\/13993003.00547-2020","DOI":"10.1183\/13993003.00547-2020"},{"key":"10.1016\/j.vaccine.2022.04.055_b0025","unstructured":"WHO. COVID-19 and NCD risk factors. [retrieved July 1, 2021] https:\/\/www.who.int\/docs\/default-source\/ncds\/un-interagency-task-force-on-ncds\/uniatf-policy-brief-ncds-and-covid-030920-poster.pdf."},{"key":"10.1016\/j.vaccine.2022.04.055_b0030","unstructured":"European Centre for Disease Prevention and Control. Risk factors and risk groups. [retrieved July 1, 2021) https:\/\/www.ecdc.europa.eu\/en\/covid-19\/latest-evidence\/risk-factors-risk-groups."},{"issue":"5","key":"10.1016\/j.vaccine.2022.04.055_b0035","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1093\/ije\/dyaa140","article-title":"Characteristics and predictors of hospitalization and death in the first 11 122 cases with a positive RT-PCR test for SARS-CoV-2 in Denmark: a nationwide cohort","volume":"49","author":"Reilev","year":"2020","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.vaccine.2022.04.055_b0040","doi-asserted-by":"crossref","first-page":"m1966","DOI":"10.1136\/bmj.m1966","article-title":"Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study","volume":"369","author":"Petrilli","year":"2020","journal-title":"BMJ"},{"issue":"20","key":"10.1016\/j.vaccine.2022.04.055_b0045","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1001\/jama.2020.6775","article-title":"Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area","volume":"323","author":"Richardson","year":"2020","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.vaccine.2022.04.055_b0050","doi-asserted-by":"crossref","first-page":"e206","DOI":"10.1093\/cid\/ciaa1012","article-title":"Risk Factors for Intensive Care Unit Admission and In-hospital Mortality Among Hospitalized Adults Identified through the US Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET)","volume":"72","author":"Kim","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"7821","key":"10.1016\/j.vaccine.2022.04.055_b0055","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41586-020-2521-4","article-title":"Factors associated with COVID-19-related death using OpenSAFELY","volume":"584","author":"Williamson","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2022.04.055_b0060","doi-asserted-by":"crossref","first-page":"m1985","DOI":"10.1136\/bmj.m1985","article-title":"Features of 20\u2009133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study","volume":"369","author":"Docherty","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2022.04.055_b0065","doi-asserted-by":"crossref","first-page":"e251","DOI":"10.1017\/S0950268820002472","article-title":"Risk factors for severe disease in patients admitted with COVID-19 to a hospital in London, England: a retrospective cohort study","volume":"148","author":"Goodall","year":"2020","journal-title":"Epidemiol Infect"},{"issue":"1","key":"10.1016\/j.vaccine.2022.04.055_b0070","doi-asserted-by":"crossref","first-page":"50","DOI":"10.2337\/dc20-1444","article-title":"Type 2 Diabetes and COVID-19-Related Mortality in the Critical Care Setting: A National Cohort Study in England, March-July 2020","volume":"44","author":"Dennis","year":"2021","journal-title":"Diabetes Care"},{"issue":"6532","key":"10.1016\/j.vaccine.2022.04.055_b0075","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1126\/science.abe6959","article-title":"Model-informed COVID-19 vaccine prioritization strategies by age and serostatus","volume":"371","author":"Bubar","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2022.04.055_b0080","unstructured":"Finnish Institute for Health and Welfare (THL), Finland. Vaccinations over time in Hospital Care Districts per age group\u2014COVID-19 vaccinations in Finland\u2014THL User Interface for Database Cubes and Reports. [retrieved March 17, 2022] https:\/\/sampo.thl.fi\/pivot\/prod\/en\/vaccreg\/cov19cov\/summary_cov19covareatime."},{"key":"10.1016\/j.vaccine.2022.04.055_b0085","unstructured":"The Social Insurance Institution of Finland. Inclusion of medicines in the reimbursement scheme. [retrieved March 30, 2022]. https:\/\/www.kela.fi\/web\/en\/inclusion-of-medicines."},{"key":"10.1016\/j.vaccine.2022.04.055_b0090","unstructured":"Finnish Institute for Health and Welfare. Vaccination order and at-risk groups for COVID-19. [retrieved July 1, 2021] https:\/\/thl.fi\/en\/web\/infectious-diseases-and-vaccinations\/what-s-new\/coronavirus-covid-19-latest-updates\/vaccines-and-coronavirus\/vaccination-order-and-at-risk-groups-for-covid-19\/vaccination-order-for-risk-groups."},{"key":"10.1016\/j.vaccine.2022.04.055_b0095","unstructured":"European Centre for Disease Prevention and Control, (ECDC). Data on the 14-day age-specific notification rate of new COVID-19 cases by the end of week 7 (week ending Sunday 21 February 2021)\u2014COVID-19 cases in Denmark, Finland, Norway and Sweden. [retrieved March 30, 2022]. https:\/\/www.ecdc.europa.eu\/en\/publications-data\/covid-19-data-14-day-age-notification-rate-new-cases."},{"issue":"4","key":"10.1016\/j.vaccine.2022.04.055_b0100","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1001\/jamapsychiatry.2020.4442","article-title":"Association of Psychiatric Disorders With Mortality Among Patients With COVID-19","volume":"78","author":"Nemani","year":"2021","journal-title":"JAMA Psychiatry"},{"issue":"2","key":"10.1016\/j.vaccine.2022.04.055_b0105","first-page":"e100183","article-title":"Clozapine is strongly associated with the risk of pneumonia and inflammation","volume":"33","author":"de Leon","year":"2020","journal-title":"Gen Psychiatr 2020;33(2):e100183,100183"},{"issue":"3","key":"10.1016\/j.vaccine.2022.04.055_b0110","doi-asserted-by":"crossref","first-page":"e0247461","DOI":"10.1371\/journal.pone.0247461","article-title":"Population risk factors for severe disease and mortality in COVID-19: A global systematic review and meta-analysis","volume":"16","author":"Booth","year":"2021","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.vaccine.2022.04.055_b0115","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/s41574-020-00462-1","article-title":"Global pandemics interconnected - obesity, impaired metabolic health and COVID-19","volume":"17","author":"Stefan","year":"2021","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.vaccine.2022.04.055_b0120","doi-asserted-by":"crossref","first-page":"154344","DOI":"10.1016\/j.metabol.2020.154344","article-title":"Diabetes, glycaemic control, and risk of COVID-19 hospitalisation: Population-based, prospective cohort study","volume":"112","author":"Hamer","year":"2020","journal-title":"Metabolism"},{"issue":"8","key":"10.1016\/j.vaccine.2022.04.055_b0125","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1080\/00325481.2020.1786964","article-title":"COVID-19 and comorbidities: a systematic review and meta-analysis","volume":"132","author":"Gold","year":"2020","journal-title":"Postgrad Med"},{"issue":"4","key":"10.1016\/j.vaccine.2022.04.055_b0130","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/s41371-020-00451-x","article-title":"COVID-19 and hypertension: risks and management. A scientific statement on behalf of the British and Irish Hypertension Society","volume":"35","author":"Clark","year":"2021","journal-title":"J Hum Hypertens"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22004959?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22004959?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:12:51Z","timestamp":1759403571000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X22004959"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":26,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S0264410X22004959"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.04.055","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.07.04.21259954","asserted-by":"object"}]},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predictors of hospitalisation and death due to SARS-CoV-2 infection in Finland: A population-based register study with implications to vaccinations","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.04.055","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}